Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Olli Arjamaa Added: 1 month ago
Author(s): Varun Sundaram Added: 11 months ago
ESC HF 25 - Safety outcomes from PRAISE-HFrEF show that glucagon-like peptide-1 receptor agonism (GLP-1 RA) treatment for heart failure with reduced ejection fraction (HFrEF) and obesity was not associated with increased risk of heart failure hospitalisation or mortality compared to placebo, with greater benefits observed in patients with higher BMI.Dr Varun Sundaram (Case Western Reserve… View more
Research Area(s) / Expertise: Job title: Director of the Christchurch Heart Institute
Professor A. Mark Richards MD(Otago) PhD(Otago) FRACP is director of the Christchurch Heart Institute. Dr Richards also holds joint appointments at the University of Otago and the National University of Singapore’s Cardiovascular Research Institute. Research interests Neurohormonal physiology and pathophysiology in cardiovascular health and disease Heart Failure Acute Coronary Syndromes… View more
Job title: Electrophysiologist and Clinical Researcher